A Call to Action: Integration of Buprenorphine Prescribing Into the Care of Persons With Human Immunodeficiency Virus and Opioid Use Disorder

During the coronavirus disease 2019 (COVID-19) pandemic, we also experienced a worsening opioid overdose epidemic. Untreated opioid use disorder (OUD) in persons with human immunodeficiency virus (HIV) is associated with worse HIV-related outcomes. Buprenorphine is a safe, evidence-based medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, A Wendy, Wilson, J Deanna, Kennedy, Amy J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384664/
https://www.ncbi.nlm.nih.gov/pubmed/36039099
http://dx.doi.org/10.1093/ofid/ofac400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384664/
https://www.ncbi.nlm.nih.gov/pubmed/36039099
http://dx.doi.org/10.1093/ofid/ofac400

Ejemplares similares